Aurora Cannabis (ACB) EBITDA Margin (2017 - 2025)
Aurora Cannabis (ACB) reported EBITDA Margin of 1.01% for Q4 2025, down 3172.0% year-over-year from 0.03% in Q4 2024, and up 98.28% quarter-over-quarter from 58.81% in Q3 2025.
Aurora Cannabis (ACB) EBITDA Margin (2017 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has 9 years of EBITDA Margin data on file, last reported at 1.01% in Q4 2025.
- EBITDA Margin for Q4 2025 came in at 1.01%, down 3172.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 26.54% (down 3028.0% YoY), and the FY2025 annual result was 1.44%, down 543.0% from the prior year.
- EBITDA Margin rose to 1.01% in Q4 2025 per ACB's latest filing, from 58.81% in the prior quarter.
- Over five years, EBITDA Margin peaked at 105.37% in Q1 2021 and troughed at 2457.91% in Q3 2021.
- A 5-year average of 217.98% and a median of 15.63% in 2021 frame the typical range for EBITDA Margin.
- On a YoY basis, EBITDA Margin climbed as much as 1481396 bps in 2021 and fell as far as 252532 bps in 2021.
- A 5-year view of EBITDA Margin shows it stood at 10.29% in 2021, then plunged by 1008 bps to 114.0% in 2022, then surged by 110 bps to 10.93% in 2023, then jumped by 181 bps to 30.72% in 2024, then slumped by 103 bps to 1.01% in 2025.
- Business Quant data shows ACB's EBITDA Margin at 1.01% in Q4 2025, 58.81% in Q3 2025, and 20.96% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -1.01% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 22.74% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -170.35% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 21.55% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -16.25% |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 46.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.01% |
| Sep 30, 2025 | -58.81% |
| Jun 30, 2025 | -20.96% |
| Mar 31, 2025 | -26.54% |
| Dec 31, 2024 | 30.72% |
| Sep 30, 2024 | -23.66% |
| Jun 30, 2024 | 1.81% |
| Mar 31, 2024 | 4.64% |
| Dec 31, 2023 | 10.93% |
| Sep 30, 2023 | -4.78% |
| Dec 31, 2022 | -114.00% |
| Sep 30, 2022 | -101.36% |
| Jun 30, 2022 | -1,243.94% |
| Mar 31, 2022 | 18.36% |
| Dec 31, 2021 | -10.29% |
| Sep 30, 2021 | -2,457.91% |
| Jun 30, 2021 | -32.24% |
| Mar 31, 2021 | 105.37% |
| Dec 31, 2020 | -16.35% |
| Sep 30, 2020 | 67.42% |